pembrolizumab
merck
['kn-412', 'pembro']
kn-412 results were presented at #esmo22 pembro+crt was associated with a favorable trend toward improved efs vs crt in patients with la-hnscc, but difference didn't reach statistical significance these results were disappointing.
may be pdl1+ pts? 
Medikal Onkolog                                                       

Medical Oncologist